Abstract |
The objective of this study was to investigate the effect of equine arteritis virus (EAV) on type I interferon (IFN) production. Equine endothelial cells (EECs) were infected with the virulent Bucyrus strain (VBS) of EAV and expression of IFN-β was measured at mRNA and protein levels by quantitative real-time RT-PCR and IFN bioassay using vesicular stomatitis virus expressing the green fluorescence protein (VSV-GFP), respectively. Quantitative RT-PCR results showed that IFN-β mRNA levels in EECs infected with EAV VBS were not increased compared to those in mock-infected cells. Consistent with quantitative RT-PCR, Sendai virus- (SeV-) induced type I IFN production was inhibited by EAV infection. Using an IFN-β promoter- luciferase reporter assay, we subsequently demonstrated that EAV nsps 1, 2, and 11 had the capability to inhibit type I IFN activation. Of these three nsps, nsp1 exhibited the strongest inhibitory effect. Taken together, these data demonstrate that EAV has the ability to suppress the type I IFN production in EECs and nsp1 may play a critical role to subvert the equine innate immune response.
|
Authors | Yun Young Go, Yanhua Li, Zhenhai Chen, Mingyuan Han, Dongwan Yoo, Ying Fang, Udeni B R Balasuriya |
Journal | BioMed research international
(Biomed Res Int)
Vol. 2014
Pg. 420658
( 2014)
ISSN: 2314-6141 [Electronic] United States |
PMID | 24967365
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- RNA, Messenger
- Viral Nonstructural Proteins
- Interferon-beta
|
Topics |
- Animals
- Arterivirus Infections
(genetics, immunology, metabolism, veterinary)
- Cricetinae
- Endothelial Cells
- Equartevirus
(genetics, immunology, metabolism)
- HEK293 Cells
- Horses
- Humans
- Immunity, Innate
- Interferon-beta
(antagonists & inhibitors, biosynthesis, genetics, immunology)
- RNA, Messenger
(biosynthesis, genetics, immunology)
- Viral Nonstructural Proteins
(genetics, metabolism)
|